Caliper Life Sciences' Third Quarter 2008 Financial Results Conference Call Notice

Caliper Life Sciences' Third Quarter 2008 Financial Results Conference Call
Notice
MONDAY, November 10, 2008 5:00 p.m. EST

HOPKINTON, Mass., Oct. 23 /PRNewswire-FirstCall/ -- Caliper Life Sciences,
Inc. (Nasdaq: CALP) will conduct a conference call discussing the company's
third quarter 2008 financial results at 5:00 p.m. EST on Monday, November 10.
Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief
Financial Officer, will host the call. Management will discuss operational
and financial results and the company's outlook for the future.
A news release discussing Caliper's third quarter 2008 financial results
will be issued Monday, November 10 at approximately 4:05 p.m. EST.
Participants please call 888.679.8034 five to ten minutes prior to the
call and use the participant passcode of 71318859. International callers can
access the call by dialing 617.213.4847 and entering the same passcode. You
may also pre-register for the call at
"https://www.theconferencingservice.com/prereg/key.process?key=P6E3NNKEA".
A live webcast of the call can be accessed at
http://www.fulldisclosure.com or on the Caliper website at
http://www.caliperLS.com in the Events section of the Investor Relations page.
A webcast replay of the call will remain available until Caliper's earnings
call for the fourth quarter of 2008.
Telephone replays of the conference call will be available approximately
two hours after the completion of the call. To access a telephone playback of
the proceedings from November 10 through November 17, dial 888.286.8010 and
use the participant passcode of 97542638. International callers can access
the playback by dialing 617.801.6888 and using the same participant passcode.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies
enabling researchers in the life sciences industry to create life-saving and
enhancing medicines and diagnostic tests more quickly and efficiently.
Caliper is aggressively innovating new technology to bridge the gap between in
vitro assays and in vivo results and then translating those results into cures
for human disease. Caliper's portfolio of offerings includes state-of-the-art
microfluidics, lab automation & liquid handling, optical imaging technologies,
and discovery & development outsourcing solutions. For more information
please visit http://www.caliperLS.com.
SOURCE Caliper Life Sciences, Inc.

Peter McAree, Chief Financial Officer of Caliper Life Sciences, Inc.,
+1-508-497-2215